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EDITORIAL
Vitamin  D  deﬁciency  in  pediatric  critical  illness:  Time
to move  on  from  observational  studies?
Deﬁciencia  de  vitamina  D  en  pacientes  pediátricos  críticos:  ¿llegó  el  tiempo
de  dejar  atrás  los  estudios  observacionales?
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sCritical  illness  occurs  in  millions  of  children  worldwide
each  year.  Novel  means  of  decreasing  mortality,  speeding
rehabilitation,  and  reducing  long  term  morbidity  would  be
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).f  great  value  to  the  children,  their  families,  and  the  health
are  system.  Unfortunately,  many  proposed  interventions
ave  limited  potential  for  widespread  impact  as  they  target
ncommon  problems  or  can  be  utilized  in  only  a  minority
f  Intensive  Care  Units  (ICUs)  due  to  cost  or  complexity.
n  this  issue  of  Revista  Chilena  de  Pediatria,  Bustos  and
olleagues  provide  data  on  a new  area  of  research  with  sig-
iﬁcant  potential  to  positively  impact  Pediatric  Intensive
are  Unit  (PICU)  outcomes  on  a  global  scale.1 Their  study
valuated  vitamin  D  status  among  critically  ill  children  in
hile,  identifying  vitamin  D  deﬁciency  to  not  only  be  com-
on  but  associated  with  greater  illness  severity  and  worse
utcome.  As  eluded  to  in  their  discussion,  optimization  of
itamin  D  status  could  represent  an  ideal  means  of  improving
ediatric  critical  care  outcomes  both  locally  and  worldwide
s  supplementation  is  generally  considered  safe,  simple  and
nexpensive.
It  has  been  close  to  100  years  since  vitamin  D  was  ﬁrst
dentiﬁed  and  deﬁcient  body  stores  convincingly  linked  to
igniﬁcant  bone  disease.  Moreover,  it  has  been  4  decades
ince  vitamin  D  was  linked  to  pathology  beyond  calcium
nd  bone.  Since,  an  impressive  number  of  observational
tudies  and  clinical  trials  have  been  performed  evaluating
he  role  of  vitamin  D  in  the  health  of  non-classical  organ
ystems  and  natural  history  of  related  disease  processes.
span˜a, S.L.U. This is an open access article under the CC BY-NC-ND
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iven  established  pleiotropy  involving  organs  central  to
he  development  and  recovery  from  critical  illness  it  is
omewhat  surprising  that  the  ICU  community  only  recently
‘discovered’’  vitamin  D.  Consider,  for  example,  that
he  ﬁrst  ICU  observational  study  suggesting  a  role  for
itamin  D  was  only  published  in  2009.2 Since  this  initial
ypothesis  generating  work  the  adult  research  community
as  wasted  little  time  performing  and  publishing  dozens
f  observational  studies  from  ICU’s  around  the  world.  With
easurements  on  tens  of  thousands  of  adult  subjects,  there
s  now  overwhelming  evidence  that  vitamin  D  deﬁciency
s  not  only  common  but  associated  with  worse  clinical
utcomes,  including  mortality.  Although  concerning,  these
ndings  have  been  received  as  an  opportunity  and  the  adult
ritical  care  community  has  proceeded  to  clinical  trials.
But  what  about  the  PICU?  Optimization  of  vitamin  D  status
ould  be  just  as,  if  not  more,  important  for  the  develop-
ng  child  struck  by  critical  illness.  Although  adult  research
s  relevant,  it  is  important  that  the  pediatric  critical  care
ommunity  separately  evaluate  the  importance  of  vitamin
 deﬁciency  and  how  best  to  approach  supplementation.
deally,  pediatric  critical  care  research  on  vitamin  D  would
roceed  in  parallel  with  adult  studies.  Regrettably  this  has
ot  been  the  case.  In  contrast  to  the  adult  research,  the  ﬁrst
ICU  studies  were  not  published  until  2012,3,4 with  vitamin
 measurements  available  from  relatively  fewer  countries
nd  on  thousands  instead  of  tens  of  thousands  of  patients.
onsequently,  observational  studies  like  the  one  performed
y  Bustos  and  colleagues  continue  to  make  important  con-
ributions  to  the  ﬁeld.  For  example,  their  results  serve  to
ot  only  verify  ﬁndings  from  previous  observational  reports,
ut  as  the  ﬁrst  study  from  South  America,  help  conﬁrm  vita-
in  D  deﬁciency  as  a  problem  on  all  inhabited  continents.  In
ddition,  Bustos  and  colleagues  have  also  contributed  impor-
ant  information  to  the  debate  about  whether  vitamin  D
tatus  is  relevant  to  clinical  outcome.  In  addition  to  repor-
ing  that  vitamin  D  deﬁciency  is  associated  with  greater
rgan  dysfunction,  Bustos  and  colleagues  have  the  distinc-
ion  of  being  the  ﬁrst  pediatric  study  to  report  a  statistically
igniﬁcant  increase  in  mortality.  Although  the  mortality  ﬁnd-
ngs  are  consistent  with  adult  research,  it  is  important  to
mphasize  that  not  all  PICU  studies  have  identiﬁed  relation-
hips  between  vitamin  D  and  clinical  course.5 The  conﬂicting
esults  may  be  a  consequence  of  small  study  sizes  and  poor
ower,  and  a  systematic  review  and  meta-analysis  has  been
nitiated  with  goal  of  pooling  data  to  more  precisely  deﬁne
he  relationship.  Nonetheless,  given  the  well-known  issue
ith  confounding  in  observational  studies,  clinical  trials  will
e  required  to  deﬁnitively  determine  whether  there  are  ben-
ﬁts  to  optimizing  vitamin  D  status  during  critical  illness.
The  potential  value  of  vitamin  D  supplementation  and
eed  for  clinical  trials  have  been  recognized  by  the  adult
CU  community,  as  evidenced  by  the  expeditious  completion
f  8  pilot  RCTs  and  a  moderate  sized  phase  III.6 Again,  what
bout  the  PICU?  To  date,  outside  of  a  small  study  focused
n  severe  burns,  there  are  no  published  clinical  trials
valuating  high  dose  vitamin  D  supplementation  in  the  PICU
etting.7 The  reason  most  likely  relates  to  both  the  delay  in
ublication  of  PICU  observational  studies  and  uncertainty
bout  how  best  to  supplement  vitamin  D  in  the  critically  ill
hild.  Although  ampliﬁed  in  pediatrics,  this  uncertainty  is
vident  in  the  adult  research  community  as  well.  A  review
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f  ICU  trials  performed  to  date  demonstrated  signiﬁcant
eterogeneity  in  the  selection  of  metabolites,  dose,  and
oute  of  administration.6 Fortunately,  the  way  forward  is
ecoming  clear  and  the  PICU  research  community  beneﬁts
rom  these  trials.  Of  the  supplementation  approaches  stud-
ed  the  enteral  loading  therapy  appears  the  most  promising
s  it  not  only  rapidly  and  safely  normalizes  vitamin  D  status
ut  appeared  to  improve  clinical  outcome.  In  the  only
hase  III  RCT  to  date  (VITdAL-ICU),  Amrein  and  colleagues
eported  that  a  540,000  IU  enteral  cholecalciferol  load
ppeared  to  decrease  mortality  and  improve  long-term
unctional  outcome  in  vitamin  D  deﬁciency  critically  ill
dults.8 Further  in  their  pilot  RCT,  Han  and  colleagues
eported  that  enteral  cholecalciferol  loading  reduced  PICU
ength  of  stay  signiﬁcantly  when  compared  to  the  placebo
roup.9 Over  the  past  two  years,  signiﬁcant  progress  has
een  made  toward  the  identiﬁcation  of  an  appropriate
osing  regimen  for  pediatrics  studies.  A  systematic  review
nd  meta-regression  of  pediatric  high  dose  vitamin  D  trials
emonstrated  weight  based  enteral  loading  of  cholecalcif-
rol  at  10,000  IU/kg  (maximum  400,000  IU)  to  be  the  most
ppropriate  regimen  for  rapid  and  safe  normalization  of
itamin  D  status.10 A  pilot  dose  evaluation  clinical  trial
as  initiated  in  2016  (VITdAL-PICU,  clinicaltrials.gov)  and
ecruitment  should  be  complete  by  the  end  of  2017.
So  what  steps  remain  and  when  will  answers  be  available
or  critically  ill  patients  and  their  health  care  providers?
ot  surprisingly,  deﬁnitive  results  should  come  sooner
n  the  adult  setting.  The  same  research  group  that  per-
ormed  the  VITdAL-ICU  trial  has  developed  a  protocol  for  a
arge  multicenter  international  phase  III  adult  trial  that  will
ocus  on  conﬁrming  that  vitamin  D  supplementation  reduces
ortality  in  critically  ill  patients  with  severe  vitamin  D
eﬁciency.  In  contrast,  it  is  unclear  when  a  large  phase  III
rial  will  be  performed  and  completed  in  the  PICU  setting.
n  addition  to  determining  the  correct  loading  regimen,  the
eld  needs  to  decide  on  the  outcome  measure  for  the  trial.
he  PICU  research  community  could  be  tempted  to  focus
n  survival,  given  the  positive  ﬁndings  in  some  observa-
ional  studies  including  the  one  by  Bustos  and  colleagues.1
lthough  it  is  often  considered  the  most  important  outcome
ollowing  critical  illness,  it  may  not  be  the  best  outcome  for
ICU  clinical  trials  for  multiple  reasons.  First,  PICU  mortal-
ty  is  often  signiﬁcantly  below  adult  rates,  and  a  focus  on
urvival  will  lead  to  large  sample  size,  raising  study  costs
nd  reducing  feasibility.  Further,  focusing  on  survival  means
hat  any  beneﬁts  related  to  other  patient  oriented  outcomes
e.g.  health  related  quality  of  life)  would  not  be  accounted
or.  This  concern  is  more  than  theoretical  as  the  adult
ITdAL-ICU  study  suggested  that  vitamin  D  deﬁcient  patients
eceiving  rapid  normalization  had  improvements  in  a  num-
er  of  long-term  outcomes  including  risk  of  respiratory  tract
nfections,  falls,  and  measures  of  physical  functioning.8
Increasingly,  vitamin  D  deﬁciency  is  being  recognized
s  a  problem  in  the  PICU.  Critically  ill  patients,  their
amilies  and  health  care  providers  want  an  answer  to  the
uestion  about  whether  to  test  for  and  rapidly  normalize
itamin  D  status.  Thanks  to  a  dedicated  ICU  community,
ike  Bustos  and  colleagues,  the  answer  will  come.  The
uestion  is  whether  it  will  come  as  fast  as  it  could?  As
 safe,  simple  and  cheap  intervention  with  potential  to
eneﬁt  both  critically  ill  adults  and  children  in  ICU’s  around
Vitamin  D  deﬁciency  in  pediatric  critical  illness  
the  world,  this  question  should  become  a  priority.  Time  will
tell  whether  it  is  treated  as  such.
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